Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used primarily to diagnose human diseases and screen donated human blood. NATs harness the power of biotechnology to detect diseases more rapidly and/or accurately than older testing methods.
|
|
|
|
| GPRO |
41.71 |
-0.29 |
| Nov 20 2009 4:00PM |
| MORE INFO |
|
